ErbB-3 Predicts Survival in Ovarian Cancer
2006 · Journal of Clinical Oncology · 230 citations
https://doi.org/10.1200/jco.2005.04.8397
M
M Schmidt
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
204
Papers
2.8K
Citations
27
h-index
51
i10-index
M Schmidt is an academic researcher from Sana Kliniken Duisburg. The author has contributed to research in topics: Pregnancy and preeclampsia studies & Birth, Development, and Health & Civil and Structural Engineering Research. The author has an h-index of 27, co-authored 174 publications.
ORCID: 0000-0003-1165-0853Papers by this author
worksInterferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response
2012 · Breast Cancer · 103 citations
https://doi.org/10.1007/s12282-012-0404-8
Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis
2001 · International Journal of Cancer · 62 citations
https://doi.org/10.1002/1097-0215(20010320)95:2<121::aid-ijc1021>3.0.co;2-n
p53 expression and resistance against paclitaxel in patients with metastatic breast cancer
2003 · Journal of Cancer Research and Clinical Oncology · 45 citations
https://doi.org/10.1007/s00432-003-0430-1
Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers
2013 · Journal of Cancer Research and Clinical Oncology · 36 citations
https://doi.org/10.1007/s00432-013-1382-8
Obesity in prenatal medicine: a game changer?
2023 · Archives of Gynecology and Obstetrics · 15 citations
https://doi.org/10.1007/s00404-023-07251-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat